- CRON is a Canadian licensed producer of cannabis.
- How much did it pay for PharmaCann? I give my estimate for the valuation that it paid for its investment in the US cannabis operator PharmaCann.
- CRON trades at a huge premium to Canadian peers like Canopy Growth and Tilray, but I explain why the premium may be warranted.
- Would Altria still invest in CRON if it made its investment today?
- I analyze the company's financials and investment prospects as compared to US peers.
For further details see:
After Cronos Finally Invests In U.S. Cannabis, Is The Stock A Buy?